Research & News

Do Financial Incentives Increase HIV Care Engagement and Retention?

Oct 23, 2015

Successful HIV care involves getting tested, initiating care, remaining in care, and taking ARVs as needed. Movement through the HIV care cascade may be helped by the use of financial incentives that reward patients for completing steps in the cascade. Researchers... Read More

Prevention of Perinatal HIV Case Review

Oct 23, 2015

Researchers in Georgia completed a case review of HIV-infected infants born between 2005-2012 for risk factors associated with mother-to-child transmission of HIV. Of the 27 cases identified, 53% of mothers did not receive ARVs during pregnancy or labor. Additionally,... Read More

WHO Guidelines on PrEP and Initiation of ARVs for HIV

Sep 15, 2015

The World Health Organization released its Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV as a early release in preparation for updating its guidelines on the use of antiretroviral therapy for treating and preventing HIV which is... Read More

Hormonal Contraception and Interactions with ARVs

Sep 01, 2015

Publications and pharmaceutical packages were reviewed to determine any contraindications for ARV co-administration with hormonal contraceptive methods (oral contraceptive pills, injectable dept medroxyprogesterone acetate [DMPA], levonorgestrel intrauterine system [LNG-... Read More

Updated Perinatal Guidelines Now Available

Aug 13, 2015

The HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission announced the release of the updated Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce... Read More

HIV Viral Load During Pregnancy Impacted by Time of Diagnosis and Prenatal Care

Jul 28, 2015

A retrospective review of HIV-positive women who delivered in Philadelphia between 2005-2013 found that women who were diagnosed HIV-positive during pregnancy were less likely to receive antiretroviral therapy and have an undetectable viral load than those diagnosed prior... Read More

FDA Approves Test to Distinguish Type of HIV Infection

Jul 28, 2015

The BioPlex 2200 HIV Ag-Ab assay has been approved by the FDA for use in distinguishing between HIV-1 antibodies, HIV-2 antibodies and the HIV-1 p24 antigen.This is approved for use in pregnant women and is another tool to aid in prevention of perinatal transmission... Read More

HIV Remission for Perinatally Infected Patient

Jul 28, 2015

A presentation at this year's International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention shared data on a patient who was diagnosed HIV-positive at 4 weeks of age, started on ART at 3 months of age (with a high viral load), and achieved an... Read More

Use of ART Prior to Conception Results in No Perinatal Transmission

Jul 27, 2015

Researchers with the French Perinatal Cohort (ANRS-EPF) determined that perinatal HIV transmission rate in their population was zero for women who were on ART prior to conception, continued throughout pregnancy and had an undetectable viral load at delivery. For women who... Read More

Next HIV-specific Prenatal Classes Begin July 2015

Jul 15, 2015

The next series of PACPI's HIV-specific prenatal classes have been scheduled for July/August 2015.  Please see the attached flyer for the class and call 312-334-0971 to enroll your clients and patients.